Pfizer to Discuss Covid-19 Vaccine Booster With U.S. Officials
A dose of the Pfizer-BioNTech Covid-19 vaccine at Boston Medical Center in Boston, Massachusetts, U.S.
Photographer: Adam Glanzman/BloombergThis article is for subscribers only.
Washington (AP) -- Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine as President Joe Biden’s chief medical adviser acknowledged that "it is entirely conceivable, maybe likely” that booster shots will be needed.
The company said it was scheduled to have the meeting with the Food and Drug Administration and other officials Monday, days after Pfizer asserted that booster shots would be needed within 12 months.